Health-Related Quality-of-Life (HRQoL) in Patients (pts) with Advanced Neuroendocrine Tumors (NET) Treated with Everolimus (EVE): Results from an Open-Label, Phase IIIb, Multicenter, Expanded Access Program (EAP)
NEUROENDOCRINOLOGY（2014）
关键词
everolimus,qol,net
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要